Search

New Clinical Trials Opening in Hematology/Oncology

Genitourinary Oncology

Primary Dreicer, Robert

CRC: Drake, Jennifer

19-20484 PHAR B-701_U22

Stages: Any/all CT.GOV ID: NCT03123055

 

A Multi-Center, Single-Arm, Open-Label Phase 1b/2 Study of a Novel FGFR3 Inhibitor (B-701) Combined with Atezolizumab in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma who have Progressed Following Platinum-based Chemotherapy

Primary Dreicer, Robert

CRC: Drake, Jennifer

19-21029 Other: National PrE0807

Stages: II; III; IV A CT.GOV ID: NCT03532451

 

 

Thoracic Oncology

ID: NCT02716116

A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 (AP32788) in Non-Small Cell Lung Cancer

Primary Gentzler, Ryan

CRC: Hockenberry, Gracie, Tubbs

18-20474 PHAR 20474

Stages: III B; IV CT.GOV ID: NCT02716116

 

A Phase III, Randomized, Double-Blind Trial of Platinum Doublet Chemotherapy +/-Pembrolizumab (MK-3475) as Neoadjuvant/Adjuvant Therapy for Participants with Resectable Stage IIB or IIIA Non-Small Cell Lung Cancer (NSCLC) (KEYNOTE-671)

Primary: Ryan Gentzler

CRC:Hockenberry, Gracie, Tubbs

Stages: II B; III A CT.GOV ID: NCT03425643

 

Filed Under: Basic Research, Clinical Research